On June 29-30, 2013, I interviewed Suleman Verjee, PhD, President and CEO of Versante International. Based in Oakland, CA, Versante is a leader in leveraging biometrics, Statistical Analysis Software (SAS) programming, and data management to provide strategic leadership for drug development plans, protocol development and regulatory submissions. Dr. Verjee, the founder of Versante, is a statistician with more than 30 years of pharmaceutical industry experience focused on assisting companies with new drug application (NDA) and biologics license application (BLA) submissions, streamlining data operations and optimizing clinical development plans. He has been associated with the development, submission and/or approval of several blockbuster drugs and retains a 100% success rate with every drug submission in which he has been actively involved....
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|